Alignment Healthcare, Inc.
For the period ended Jun 30, 2025. Filed Jul 30, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Jul 30, 2025
ALHC$7.27-1.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Operations
(amounts in thousands, except share and per share amounts)
| Three Months Ended June 30, | Six Months Ended June 30, | |||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Revenues: | ||||
| Earned premiums | $1,006,203 | $674,094 | $1,924,246 | $1,295,650 |
| Other | 9,085 | 7,192 | 17,974 | 14,237 |
| Total revenues | 1,015,288 | 681,286 | 1,942,220 | 1,309,887 |
| Expenses: | ||||
| Medical expenses | 881,740 | 605,312 | 1,702,640 | 1,178,530 |
| Selling, general, and administrative expenses | 103,797 | 87,863 | 207,628 | 178,375 |
| Depreciation and amortization | 7,003 | 6,493 | 14,597 | 12,470 |
| Total expenses | 992,540 | 699,668 | 1,924,865 | 1,369,375 |
| Income (loss) from operations | 22,748 | (18,382) | 17,355 | (59,488) |
| Other expenses: | ||||
| Interest expense | 3,950 | 5,691 | 7,900 | 11,118 |
| Other income, net | (79) | (92) | (89) | (50) |
| Total other expense | 3,871 | 5,599 | 7,811 | 11,068 |
| Income (loss) before income taxes | 18,877 | (23,981) | 9,544 | (70,556) |
| Provision for income taxes | 3,224 | 22 | 3,245 | 22 |
| Net income (loss) | $15,653 | $(24,003) | $6,299 | $(70,578) |
| Less: Net income (loss) attributable to noncontrolling interest | (14) | 7 | (254) | (47) |
| Net income (loss) attributable to Alignment Healthcare, Inc. | $15,667 | $(24,010) | $6,553 | $(70,531) |
| Net income (loss) per share attributable to Alignment Healthcare, Inc.: | ||||
| Basic | 0.08 | (0.13) | 0.03 | (0.37) |
| Diluted | 0.07 | (0.13) | 0.03 | (0.37) |
| Weighted-average common shares outstanding: | ||||
| Basic | 198,328,613 | 190,891,787 | 195,980,569 | 189,948,725 |
| Diluted | 209,519,629 | 190,891,787 | 201,576,078 | 189,948,725 |
Condensed Consolidated Statements of Stockholders' Equity
| Common Stock | ||||||
|---|---|---|---|---|---|---|
| Shares | Amount | Additional Paid-In Capital | AccumulatedDeficit | Noncontrolling Interest | Total | |
| Balance at March 31, 2025 | 197,667,653 | $198 | $1,125,340 | $(1,017,407) | $864 | $108,995 |
| Net income (loss) | — | — | — | 15,667 | (14) | 15,653 |
| Issuance of common stock upon vesting of restricted stock units | 191,477 | — | — | — | — | — |
| Equity-based compensation | — | — | 15,553 | — | — | 15,553 |
| Stock options exercised | 99,107 | — | 1,616 | — | — | 1,616 |
| Sale of consolidated subsidiary | — | — | — | — | (850) | (850) |
| Balance at June 30, 2025 | 197,958,237 | $198 | $1,142,509 | $(1,001,740) | $— | $140,967 |
| Common Stock | ||||||
|---|---|---|---|---|---|---|
| Shares | Amount | Additional Paid-In Capital | AccumulatedDeficit | Noncontrolling interest | Total | |
| Balance at March 31, 2024 | 191,156,569 | $191 | $1,057,519 | $(926,779) | $1,086 | $132,017 |
| Net income (loss) | — | — | — | (24,010) | 7 | (24,003) |
| Issuance of common stock upon vesting of restricted stock units | 80,178 | — | — | — | — | — |
| Equity-based compensation | — | — | 16,784 | — | — | 16,784 |
| Balance at June 30, 2024 | 191,236,747 | $191 | $1,074,303 | $(950,789) | $1,093 | $124,798 |
Condensed Consolidated Statements of Stockholders' Equity
| Common Stock | ||||||
|---|---|---|---|---|---|---|
| Shares | Amount | Additional Paid-In Capital | AccumulatedDeficit | Noncontrolling interest | Total | |
| Balance at December 31, 2024 | 191,778,639 | $192 | $1,107,952 | $(1,008,293) | $1,104 | $100,955 |
| Net income (loss) | — | — | — | 6,553 | (254) | 6,299 |
| Issuance of common stock upon vesting of restricted stock units | 6,056,296 | — | — | — | — | — |
| Forfeitures | (277) | — | — | — | — | — |
| Equity-based compensation | — | 6 | 32,734 | — | — | 32,740 |
| Stock Options exercised | 123,579 | — | 1,823 | — | — | 1,823 |
| Sale of consolidated subsidiary | — | — | — | — | (850) | (850) |
| Balance at June 30, 2025 | 197,958,237 | $198 | $1,142,509 | $(1,001,740) | $— | $140,967 |
| Common Stock | ||||||||
|---|---|---|---|---|---|---|---|---|
| Shares · Amount · Additional Paid-In Capital · AccumulatedDeficit · Noncontrolling interest · Total | ||||||||
| Balance at December 31, 2023 | 188,951,643 | $189 | $1,037,015 | $(880,258) | $1,125 | $158,071 | ||
| Net income (loss) | — | — | — | (70,531) | (47) | (70,578) | ||
| Issuance of common stock upon vesting of restricted stock units | 2,357,723 | 2 | — | — | 2 | |||
| Forfeitures | (2,799) | — | — | — | — | — | ||
| Shares withheld related to net restricted stock settlement | (69,820) | (350) | (350) | |||||
| Equity-based compensation | — | — | 37,638 | — | — | 37,638 | ||
| Repurchase of noncontrolling interest attributable to subsidiary | — | — | — | — | 15 | 15 | ||
| Balance at June 30, 2024 | 191,236,747 | $191 | $1,074,303 | $(950,789) | $1,093 | $124,798 | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.